-
A significant reduction in systolic and diastolic blood pressure was observed in individuals with newly diagnosed stage 1 hypertension treated with garlic. Increasing effects were observed in a dose- and duration-dependent manner.
-
This population-based, case-control study suggests that dietary intake of peppers and related species may be associated with decreased risk of Parkinson's disease.
-
Data collected from a large study involving four countries show no effect of alcohol exposure in varying degrees on the rate of preterm birth, low birth weight, average birth weight, and preeclampsia.
-
Novel protocols with functional MRI may allow clinicians to determine if some unresponsive patients are able to hear, understand, and respond to questions.
-
This paper summarizes and focuses on the National General Practice Study of Epilepsy with emphasis on epilepsy prognosis after initial diagnosis.
-
By William T. Elliott, MD
-
The authors concluded that in a diverse, community-based population with new systolic heart failure, spironolactone did not reduce death or hospitalization, but did increase the incidence of hyperkalemia.
-
Among patients with mild-to-moderate Alzheimer's disease, 2000 IU/d of vitamin E resulted in a slower functional decline and a decrease in the caregiver burden.
-
A second sodium-glucose cotransporter 2 (sglt2) inhibitor has been approved for the treatment of adults with type 2 diabetes mellitus. These agents increase glucose secretion by inhibiting reabsorption in the kidney. Renal glucose threshold can be lowered to 70-90 mg/dL from a norm of 240 mg/dL in patients with diabetes. Dapagliflozin follows canagliflozin as the second SGLT2 approved and is marketed by Bristol-Myers Squibb and AstraZeneca as Farxiga.
-
